Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing. While most basic research occurs in academia, contributions from industry are also undeniably ...

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing. Continuous processing for the production of key building blocks and intermediates for ...

Ajinomoto OmniChem, an innovative provider of small molecule API, contract development and manufacturing services, today announced the successful completion of a commercial scale manufacturing ...